Items tagged with Treatment

Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates (post with simple image)

Bedaquiline combined with other active drugs has the potential to achieve high culture conversion rates in advanced MDR- and XDR-TB cases. However, it is crucial to follow carefully all patients for severe adverse events, even after bedaquiline discontinuation.

WHO interim guidance on the use of delamanid in the treatment of MDR-TB (post with simple image)

The guidance lists five conditions that must be in place if delamanid is used to treat adults with MDR-TB.

“You see yourself vanishing and you think: I’m going to die” (post with simple image)

Andaleeb Rinquest remembers the moment she accepted, with certainty, the imminence of her own death.

Drug-resistant tuberculosis patients face dwindling treatment options (post with simple image)

Doctors believe there is greater drug resistance and complexity of TB, which disproportionally affects immigrants.

Latent TB: Shorter course of therapy effective in children (post with simple image)

In children with latent tuberculosis, 3 months of combined therapy with isoniazid and rifapentine is safe and as effective as 9 months of isoniazid alone.

Drug-resistant tuberculosis a tiny — but potent — foe in L.A. County (post with simple image)

Otsuka rejected Dr. Caitlin Reed’s attempt to obtain delamanid for her patient, Gary, who has the most drug-resistant case of TB ever identified in the United States.

Inside India: The deadly effects of red tape (post with simple image)

Red tape and over-regulation can kill.

Zimbabwe faces troubling spike in cases of multidrug-resistant TB (post with simple image)

HARARE, Jan 25 2015 (IPS) - About eight years ago, 44-year-old Tilda Chihota was struck with tuberculosis which kept her bed-ridden for over six months at her rural home in Zimbabwe’s Mwenezi district, 144 kilometres southwest of Masvingo, the country’s oldest town.

Phase 2a published results show the potential of a new TB regimen with novel drugs bedaquiline and pretomanid (PA-824) (post with simple image)

Results of study testing BPaZ published in American Journal of Respiratory and Critical Care Medicine; Regimen now being tested in Phase 2b clinical trial

TB Alliance advances next-generation TB drug candidate into clinical testing (post with simple image)

TBA-354 is the first potential tuberculosis drug to advance to Phase 1 trial in six years.

Page 50 of 58 · Total posts: 0

←First 49 50 51 Last→